WO2011102640A3 - Method for preparing sitagliptin and amine salt intermediates used therein - Google Patents
Method for preparing sitagliptin and amine salt intermediates used therein Download PDFInfo
- Publication number
- WO2011102640A3 WO2011102640A3 PCT/KR2011/001024 KR2011001024W WO2011102640A3 WO 2011102640 A3 WO2011102640 A3 WO 2011102640A3 KR 2011001024 W KR2011001024 W KR 2011001024W WO 2011102640 A3 WO2011102640 A3 WO 2011102640A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- amine salt
- intermediates used
- preparing sitagliptin
- salt intermediates
- sitagliptin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention relates to a method for preparing sitagliptin by using an amine salt of (3R)-3-azido-4-(2,4,5-trifluorophenyl)-butyric acid (formula (V)) in a high yield and purity, and amine salt intermediates used therein.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100015273A KR101156587B1 (en) | 2010-02-19 | 2010-02-19 | Preparation method of sitagliptin and amine salt intermediate used therein |
KR10-2010-0015273 | 2010-02-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011102640A2 WO2011102640A2 (en) | 2011-08-25 |
WO2011102640A3 true WO2011102640A3 (en) | 2012-01-19 |
Family
ID=44483461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2011/001024 WO2011102640A2 (en) | 2010-02-19 | 2011-02-16 | Method for preparing sitagliptin and amine salt intermediates used therein |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101156587B1 (en) |
WO (1) | WO2011102640A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130289276A1 (en) * | 2010-10-08 | 2013-10-31 | Cadila Healthcare Limited | Process for preparing an intermediate of sitagliptin via enzymatic conversion |
US20140336196A1 (en) * | 2011-05-27 | 2014-11-13 | Merck Sharp & Dohme Corp. | Phosphoric acid salts of sitagliptin |
EP2615080A1 (en) | 2012-01-12 | 2013-07-17 | LEK Pharmaceuticals d.d. | Preparation of Optically Pure ß-Amino Acid Type Active Pharmaceutical Ingredients and Intermediates thereof |
CZ2012111A3 (en) | 2012-02-16 | 2013-08-28 | Zentiva, K.S. | Process for preparing rivaroxaban based on the use of (S)-epichlorohydrin |
CN102627648B (en) * | 2012-04-14 | 2014-11-12 | 江苏施美康药业股份有限公司 | Preparation method of sitagliptin |
CA2881050A1 (en) | 2012-08-08 | 2014-02-13 | Cipla Limited | Process for the preparation of sitagliptin and intermediate compounds |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005003135A1 (en) * | 2003-06-24 | 2005-01-13 | Merck & Co., Inc. | Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
WO2007035198A2 (en) * | 2005-07-25 | 2007-03-29 | Merck & Co., Inc. | Dodecylsulfate salt of a dipeptidyl peptidase-iv inhibitor |
WO2011049344A2 (en) * | 2009-10-21 | 2011-04-28 | Hanmi Holdings Co., Ltd. | Method of preparing sitagliptin and intermediates used therein |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
KR20070111099A (en) * | 2006-05-16 | 2007-11-21 | 영진약품공업주식회사 | Novel crystalline form of sitagliptin hydrochloride |
KR101014885B1 (en) * | 2008-07-09 | 2011-02-15 | 강원대학교산학협력단 | Synthesis of allyl benzene derivatives using Pd and ligand |
-
2010
- 2010-02-19 KR KR1020100015273A patent/KR101156587B1/en not_active IP Right Cessation
-
2011
- 2011-02-16 WO PCT/KR2011/001024 patent/WO2011102640A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005003135A1 (en) * | 2003-06-24 | 2005-01-13 | Merck & Co., Inc. | Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
WO2007035198A2 (en) * | 2005-07-25 | 2007-03-29 | Merck & Co., Inc. | Dodecylsulfate salt of a dipeptidyl peptidase-iv inhibitor |
WO2011049344A2 (en) * | 2009-10-21 | 2011-04-28 | Hanmi Holdings Co., Ltd. | Method of preparing sitagliptin and intermediates used therein |
Non-Patent Citations (2)
Title |
---|
HANSEN, KARL B. ET AL.: "First Generation Process for the Preparation of the DPP-IV Inhibitor Sitagliptin", ORGANIC PROCESS RESEARCH & DEVELOPMENT, vol. 9, 2005, pages 634 - 639 * |
KIM, DOOSEOP ET AL.: "(2R)-4-0xo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]tr iazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Pot ent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of T epe 2 Diabetes", J. MED. CHEM., vol. 48, 2005, pages 141 - 151 * |
Also Published As
Publication number | Publication date |
---|---|
WO2011102640A2 (en) | 2011-08-25 |
KR20110095672A (en) | 2011-08-25 |
KR101156587B1 (en) | 2012-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ600119A (en) | Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives | |
WO2012138147A3 (en) | 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid crystalline form and the producing method thereof | |
WO2012103279A3 (en) | Methods and compositions for the synthesis of multimerizing agents | |
WO2011087316A3 (en) | Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same | |
WO2011102640A3 (en) | Method for preparing sitagliptin and amine salt intermediates used therein | |
MX352470B (en) | Malonic acid di-salts and a method for preparing malonyl dihalides. | |
WO2008096372A3 (en) | Process for preparing highly pure ezetimibe using novel intermediates | |
MY150280A (en) | Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid | |
MX2014014138A (en) | New process for the preparation of 2-cyclopentyl-6-methoxy-isonic otinic acid. | |
MX2011009898A (en) | Process for the preparation of propionic acid derivatives. | |
WO2010004578A3 (en) | Novel and improved processes for the preparation of paliperidone | |
WO2012093411A3 (en) | Process for the preparation of r-(-)-3- (carbamoylmethyl)-5-methylhexanoic acid and the intermediates | |
WO2012176214A3 (en) | Process for bendamustine hydrochloride | |
WO2012112841A3 (en) | [1,2,4]oxadiazol-3-yl acid salts and crystalline forms and their preparation | |
MX2010009926A (en) | New process for the preparatiion of cyclohexanecarboxylic acid dericatives. | |
AP2007004270A0 (en) | Process for preparing salts of hydrocyanic acid | |
MY164880A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
IN2014CN02346A (en) | ||
MX2010009876A (en) | New process for the preparation of cyclohexanecarboxylic acid derivatives via the corresponding cyclohexanecarboxamide derivative. | |
IN2014MN00971A (en) | ||
AU2011300642A1 (en) | Process for producing crystalline 5-aminosalicylic acid | |
WO2012044043A3 (en) | Novel method of preparing benzoimidazole derivatives | |
WO2011007136A3 (en) | Process for the preparation of o-desmethyl venlafaxine and intermediate for use therein | |
WO2009060297A3 (en) | An improved process for the preparation of paliperidone and its intermediates | |
WO2009122429A3 (en) | Crystalline oxybutynin and process for preparing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11744882 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11744882 Country of ref document: EP Kind code of ref document: A2 |